Home > Clinical Trials
Check All Search

Saved trials

NOT_YET_RECRUITING
NCT07746882
Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy
680 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Stroke


Acute Ischemic Stroke
ACTIVE_NOT_RECRUITING
NCT03742102
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
243 Enrollment(s)
32 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Triple Negative Breast Neoplasms
ACTIVE_NOT_RECRUITING
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
138 Enrollment(s)
37 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Breast Cancer
RECRUITING
NCT07548710
Study of SA+X in the Treatment of Newly Diagnosed AML
205 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia
RECRUITING
NCT06486883
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
200 Enrollment(s)
79 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Breast Cancer


Advanced Breast Carcinoma


Hormone Receptor Positive Breast Carcinoma
ACTIVE_NOT_RECRUITING
NCT04784715
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
1,157 Enrollment(s)
283 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer; HER2-positive; Metastatic
NOT_YET_RECRUITING
NCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
32 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Migraine Disease


Patent Foramen Ovale
RECRUITING
NCT07022483
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
710 Enrollment(s)
75 Study location(s)
INTERVENTIONAL (PHASE3)
Endometrial Cancer